NewMediaWire
SILICON VALLEY, CA - May 9, 2025 (NEWMEDIAWIRE) - ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company developing botanical-based therapies for central nervous system (CNS), ophthalmology, and oncology/hematology indications, today announced that the Japan Patent Office has granted a new patent protection for its Major Depressive Disorder (MDD) candidate, ABV-1504. The patent, valid through 2040, strengthens ABVC’s global intellectual property... (continue reading...)
Expansion Marks Fourth Location, Reinforces Metavesco’s Aggressive Road-map Toward 98 Epic Labor Branches by 2029
CUMMING, GA - May 9, 2025 (NEWMEDIAWIRE) - Metavesco, Inc. (OTC PINK: MVCO) ("Metavesco" or the "Company"), a trailblazing holding company, today announced the grand opening of its newest Epic Labor branch in Baltimore, Maryland. The launch positions Epic Labor, a wholly owned subsidiary, at the heart of a booming construction, logistics, and hospitality... (continue reading...)
SIERRA BLANCA, TEXAS - May 9, 2025 (NEWMEDIAWIRE) - Texas Mineral Resources Corp. (OTCQB: TMRC)
Texas Mineral Resources Corp. (“TMRC” or the “Company”) is pleased to announce the appointment of Jonathan Beigle to the TMRC Board of Directors, effective May 8, 2025. Mr. Beigle will serve as a member of the Audit Committee of the Board. Following the appointment of Mr. Beigle, the Board will be comprised of six directors, five of whom are independent.
"We are pleased... (continue reading...)
CONCORD, NC - May 8, 2025 (NEWMEDIAWIRE) - Hydromer, Inc. (OTC: HYDI) (the “Company”), a leader in hydrophilic, thromboresistant, and antimicrobial coating technologies for medical devices for over 44 years, today announced certain preliminary, unaudited financial results for the first quarter ended March 31, 2025. These results are based on the most current information available to management, are unaudited, and are subject to the completion of the Company’s 2025... (continue reading...)
GEO-CM04S1 Demonstrates Robust COVID-19 and Mpox Immunogenicity in Immunocompromised Patients and Healthy Adults
ATLANTA, GA - May 8, 2025 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing immunotherapies and vaccines against infectious diseases and solid tumor cancers, today recapped the presentation of clinical and translational data for its next-generation multi-antigen COVID-19 vaccine candidate, GEO-CM04S1,... (continue reading...)
More NewMediaWire
View Older Stories-
GeoVax Expands Gedeptin® Patent Portfolio
-
Forian Inc. to Announce First Quarter 2025 Results on May 14, 2025
-
GeoVax Applauds White House Executive Order Supporting U.S. Pharmaceutical Manufacturing; Highlights Progress in Domestic MVA Vaccine Production
-
GeoVax Reports First Quarter 2025 Financial Results and Provides Business Update
-
AppSwarm Announces Acquisition of AI-Powered "Health Note" Calmi App to Bolster Health and Wellness Application Portfolio
-
United Health Products Announces OTCQB Uplisting and FDA Update
-
ABVC BioPharma Announces First Quarter 2025 Financial Results and Strategic Planning for AI-Driven Agricultural Project in Taiwan
-
Geopulse Exploration, Inc. Completes Acquisition of ATC Services
-
TCRG Announces Formation of Transition Team to Support Upcoming Strategic Transaction
-
GeoVax Presents Gedeptin® Clinical Data at the American Association for Cancer Research Annual Meeting
-
Neutra Corp's Subsidiary, Neutra Life Sciences, Expands Rapidly With New Joint Venture Partnerships
-
CyberloQ Technologies, Inc. Issues Shareholder Update on SOC 2 Compliance, New Patent Filing, 8K Filing With SEC
-
CMUV Bancorp Announces 2025 1st Quarter Financial Results & Notice of Special Shareholder Meeting
-
Quantumzyme Highlights Benefits and Commercialization Opportunities of Pending Breakthrough Green Chemistry Patent
-
Metavesco Publishes Co-Owners Manual to Shareholders, Setting a New Standard for the OTC Market
-
GeoVax Responds to Detection of Clade I Mpox in North Carolina Wastewater
-
GeoVax Highlights Strong Clinical Results Following Presentation of Multi-Antigen COVID-19 Vaccine at the 25th Annual World Vaccine Congress
-
Peapack Private Bank & Trust Looking Ahead to Long Island
-
VPR Brands, LP Secures Exclusive Distribution Deal With Associated Supply LLC for ELF Brand Expansion Into New York Cannabis Market
-
Quantumzyme Anticipates Publication of Transformative Patent for Enzymatic Ibuprofen Manufacturing
-
GeoVax to Report First Quarter 2025 Financial Results and Provide Corporate Update on May 1, 2025
-
GeoVax Appoints Dr. Senthil Ranganathan as Vice President, Technical Development and CMC Operations
-
Cavitation Technologies, Inc. Announces the Completion of Cavitation Non-Thermal Plasma System to Address the Global Water Crisis
-
Peapack Private Bank & Trust Now Open in NYC
-
Royalty Management Holding Corporation Provides Update on Its Portfolio and Investment Alignment With US Critical Mineral Strategy
-
GeoVax Highlights New Study Demonstrating the Strength of Multi-Antigen COVID-19 Vaccine Candidates
-
Yuengling's Ice Cream Corporation (OTC: YCRM), Doing Business as ReachOut, Files 2024 10-K With Profitability, Growth, and Corporate Transformation in Focus
-
UPDATE: ABVC BioPharma Announces 2024 Financial Results
-
GeoVax Provides Update on BARDA Project NextGen and Outlines 2025 Business Momentum
-
Quantumzyme Highlights Enzyme Engineering Platform and Ongoing Work in Sustainable Ibuprofen Synthesis
-
ABVC BioPharma Announces 2024 Financial Results
-
GeoVax to Present at the Emerging Growth Conference on April 16, 2025
-
GeoVax to Present Clinical Data at Upcoming April Industry Events
-
Royalty Management Holding Corporation Pre-Announces Record Breaking First Quarter 2025 Revenues of Approximately $973,000
-
Quantumzyme: Advancing Enzymatic Innovation for a Sustainable Industrial Future
-
Can B Corp.'s Nascent Pharma Hires Fox Rothschild to Defend and Monetize Its Two Cannabis Patents Valued at $122 Million and Potentially in Excess of $750 Million
-
GeoVax Receives USPTO Notice of Allowance for Marburg Hemorrhagic Fever Vaccine Patent
-
Quantumzyme Introduces Manu Bharath Khareedhi as Independent Director, Looks to Strengthen Strategic Growth and Innovation
-
Blackwell 3D Appoints Urban Aura Interior Design LLC for Dubai South Project Interior Design
-
REMSleep is in Process of Signing Agreement With Major Distributor
-
Splash Beverage Group Addresses Notice From NYSE
-
TCRG Executes Letter of Intent (LOI) to Acquire $35 Million in AgTech and Sensor Technology Assets
-
Wytec Prepares for 1st AI Gunshot Detection Pilot
-
Fortran Corporation Announces Conversion of Debenture & Acquisition Completion
-
ABVC's Subsidiary AiBtl Signs Share-for-Land Agreement in Asia With Deal Valued at USD $7.67 Million
-
Over $1 Million in Revenue With Continued Profitability Projected in the First Half of 2025 for High Demand Product in the Homebuilding Sector from Innovative Designs, Inc. (IVDN)
-
Neutra Corp Signs Letter of Intent to Acquire CuraConnector.com, Inc., Expanding Into Healthcare Information & Digital Technology
-
Forian Inc. Announces Restatement of Previously Issued Financials and Affirms 2024 Outlook
-
ILUS Announces Date for Its Annual Shareholder Meeting
-
United Health Products Provides Update on FDA and OTC Markets Applications
